Hot Papers

Eugene Garfield Our reader surveys indicate that "Hot Papers" is one of our most popular editorial features. When and how did it begin? After the Science Citation Index was launched in the '60s, we soon learned that the age of the average cited paper, depending upon the field, was 5 to 15 years old. In molecular biology, while 25 percent of cited papers were about 2 years old, the rest were much older. These data initially obscured the fact that a small group of papers were well ci

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

After the Science Citation Index was launched in the '60s, we soon learned that the age of the average cited paper, depending upon the field, was 5 to 15 years old. In molecular biology, while 25 percent of cited papers were about 2 years old, the rest were much older. These data initially obscured the fact that a small group of papers were well cited within months of publication. It wasn't until 1975 that a series of essays in Current Contents identified the 100 most-cited life science papers published in the current year.1

Two years after we started The Scientist, we began a feature called "Hot Papers." A group of experts was assigned the "subjective" task of compiling lists of current articles they considered to be significant--that is, "hot." These selections were not based on "objective" citation data. However, the process proved to be problematic.

In February 1989,2 I announced ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies